Pharmacogenomics and the Treatment of Sporadic Alzheimer's Disease:A Decade of Progress

E-ISSN： 1875-6913|6|1|63-76

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.6, Iss.1, 2008-01, pp. : 63-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives

By Fisher A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1395-1412

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics and therapeutic prospects in Alzheimer’s disease

By Cacabelos Ramón

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 1967-1987

Informa Healthcare

Access to resources Recommend Favorite

Treatment strategies in Alzheimer's disease

By Levy R.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 204-205

Elsevier

Access to resources Recommend Favorite

Aripiprazole in the treatment of Alzheimer's disease

By De Deyn Peter Paul Drenth Annemieke FJ Kremer Berry P Oude Voshaar Richard C Van Dam Debby

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 459-474

Informa Healthcare

Access to resources Recommend Favorite

Diagnosis and Treatment of Alzheimer's Disease

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 1, 2005-03 ,pp. : 5-13

Bentham Science Publishers

Access to resources Recommend Favorite